DAJY(SZ:002030)2025-09-25 11:16Group 1: Company Strengths and Market Position - The company maintains a high customer retention rate among top-tier hospitals, which is a core asset [3] - The company is actively expanding into new markets such as research and disease control while optimizing its product structure [3] - The domestic in vitro diagnostic market is maturing, accelerating the process of local products replacing imports, providing growth opportunities [4] Group 2: Future Strategies and Innovations - The company is focused on vertical deepening and horizontal integration within the IVD field, with a newly established strategic planning department to identify investment opportunities [3] - Continuous innovation in product development is prioritized, with a focus on enhancing precision and speed in molecular diagnostics [4] - The company is exploring mergers and acquisitions that align with its existing business to enhance the industry chain [3] Group 3: Market Expansion and Competition - The company's overseas business currently represents a small portion of revenue, primarily in Latin America and Southeast Asia, and requires time for development [4] - The company is committed to enhancing its service quality and market competitiveness through a diverse range of diagnostic technologies [4] - The company actively communicates with investors through various channels to improve understanding and recognition of its business strategies [4]